recombinant human igf2 Search Results


93
R&D Systems recombinant human igf ii
Recombinant Human Igf Ii, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+igf2/Recombinant+Human+IGF-II%2FIGF2+Protein%2C+CF/pm17359288-30-0-13
Average 93 stars, based on 1 article reviews
recombinant human igf ii - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

94
R&D Systems human recombinant igf 2
Human Recombinant Igf 2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+igf2/Recombinant+Human+IGF-II%2FIGF2+Protein%2C+CF/pmc04608384-153-0-17
Average 94 stars, based on 1 article reviews
human recombinant igf 2 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

93
Proteintech recombinant human igf ii
Recombinant Human Igf Ii, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+igf2/Animal-free+Recombinant+Human+pro+IGF-II/pmc11465228-127-22-25
Average 93 stars, based on 1 article reviews
recombinant human igf ii - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

92
MedChemExpress igf1 inhibitor xentuzumab
Igf1 Inhibitor Xentuzumab, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+igf2/Xentuzumab/pm38759655-442-5-8
Average 92 stars, based on 1 article reviews
igf1 inhibitor xentuzumab - by Bioz Stars, 2026-09
92/100 stars
  Buy from Supplier

90
Novozymes limited recombinant human igf2
Recombinant Human Igf2, supplied by Novozymes limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+igf2/recombinant+human+igf2/10__1677_slash_jme___08___0154-59-0-5
Average 90 stars, based on 1 article reviews
recombinant human igf2 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Biomol GmbH igf-ii protein (human recombinant (rhu)igf-2; biomol #arg70131.100
Igf Ii Protein (Human Recombinant (Rhu)igf 2; Biomol #Arg70131.100, supplied by Biomol GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+igf2/igf+ii+protein++human+recombinant++rhu+igf+2++biomol++arg70131+100/pmc09187574-121-7-12
Average 90 stars, based on 1 article reviews
igf-ii protein (human recombinant (rhu)igf-2; biomol #arg70131.100 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
GENTAUR Inc human recombinant igf2 / fetus
Human Recombinant Igf2 / Fetus, supplied by GENTAUR Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+igf2/human+recombinant+igf2+++fetus/pm28910276-64-25-32
Average 90 stars, based on 1 article reviews
human recombinant igf2 / fetus - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

86
Novoprotein recombinant human igf2
Plagl1 deficiency leads to downregulated <t>IGF2</t> and increased glucose metabolism. a Protein-protein interaction analysis for the relationship between PLAGL1 and genes activated by osteogenic induction while inhibited by knockdown of Plagl1 . b Western blot analysis of the expression of IGF2 during osteogenic induction. c Western blot analysis of the expression of IGF2 after knockdown of Plagl1 . d , e Immunofluorescence staining of IGF2 (green) and DAPI (cyan) in condyles of control and Wnt1-Cre;Plagl1 pat fl/+ mice at PN 28.5. The boxes ( d1, e1 ) show the magnified regions on the right. White arrows show the positive signals. n = 3 per group. Scale bars, 50 μm. f Western blot analysis of the expression of IGF2 in the subchondral bone after knockdown of Plagl1 . Band intensities of IGF2 normalized to β-actin. n = 3 per group. Unpaired two-tailed t-test was used for statistical analysis. GSEA plots of GO term 0006119 ( g ) and 0061621 ( h ) between AdV-EGFP and AdV-CRE-EGFP transfected condyle mesenchymal cells after 4 days of osteogenic induction. n = 3 per group. Analysis of glucose uptake ( i ), intracellular ATP levels ( j ), oxygen consumption rate ( k ), reactive oxygen species ( l ), and L-lactate production ( m ) in AdV-EGFP and AdV-CRE-EGFP transfected condyle mesenchymal cells after 4 days of osteogenic induction. n = 4 per group for i. n = 3 per group for j, k, m. n = 9 per group for l. Unpaired two-tailed t-test was used for statistical analysis. The results are presented as the mean ± standard deviation (SD). * P < 0.05. ns, no significant difference
Recombinant Human Igf2, supplied by Novoprotein, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+igf2/human+igf2+recombinant/pmc12462451-248-15-18
Average 86 stars, based on 1 article reviews
recombinant human igf2 - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

90
Kingfisher Biotech multi-species (cynomolgus monkey, guinea pig, human) igf-2 recombinant protein
Plagl1 deficiency leads to downregulated <t>IGF2</t> and increased glucose metabolism. a Protein-protein interaction analysis for the relationship between PLAGL1 and genes activated by osteogenic induction while inhibited by knockdown of Plagl1 . b Western blot analysis of the expression of IGF2 during osteogenic induction. c Western blot analysis of the expression of IGF2 after knockdown of Plagl1 . d , e Immunofluorescence staining of IGF2 (green) and DAPI (cyan) in condyles of control and Wnt1-Cre;Plagl1 pat fl/+ mice at PN 28.5. The boxes ( d1, e1 ) show the magnified regions on the right. White arrows show the positive signals. n = 3 per group. Scale bars, 50 μm. f Western blot analysis of the expression of IGF2 in the subchondral bone after knockdown of Plagl1 . Band intensities of IGF2 normalized to β-actin. n = 3 per group. Unpaired two-tailed t-test was used for statistical analysis. GSEA plots of GO term 0006119 ( g ) and 0061621 ( h ) between AdV-EGFP and AdV-CRE-EGFP transfected condyle mesenchymal cells after 4 days of osteogenic induction. n = 3 per group. Analysis of glucose uptake ( i ), intracellular ATP levels ( j ), oxygen consumption rate ( k ), reactive oxygen species ( l ), and L-lactate production ( m ) in AdV-EGFP and AdV-CRE-EGFP transfected condyle mesenchymal cells after 4 days of osteogenic induction. n = 4 per group for i. n = 3 per group for j, k, m. n = 9 per group for l. Unpaired two-tailed t-test was used for statistical analysis. The results are presented as the mean ± standard deviation (SD). * P < 0.05. ns, no significant difference
Multi Species (Cynomolgus Monkey, Guinea Pig, Human) Igf 2 Recombinant Protein, supplied by Kingfisher Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+igf2/Multi-species+(Cynomolgus+Monkey%2C+Guinea+Pig%2C+Human)+IGF-2+Recombinant+Protein/custom%40rp1581h%4032648312
Average 90 stars, based on 1 article reviews
multi-species (cynomolgus monkey, guinea pig, human) igf-2 recombinant protein - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

N/A
Purified recombinant protein of Human insulin like growth factor 2 somatomedin A IGF2 transcript variant 1
  Buy from Supplier

N/A
Recombinant human IGF2 (ADO21454.1) (Ala25-Glu91) was expressed.http://www.creativebiomart.net/Recombinant-Human-IGF2-Protein-464281.htm
  Buy from Supplier

Image Search Results


Plagl1 deficiency leads to downregulated IGF2 and increased glucose metabolism. a Protein-protein interaction analysis for the relationship between PLAGL1 and genes activated by osteogenic induction while inhibited by knockdown of Plagl1 . b Western blot analysis of the expression of IGF2 during osteogenic induction. c Western blot analysis of the expression of IGF2 after knockdown of Plagl1 . d , e Immunofluorescence staining of IGF2 (green) and DAPI (cyan) in condyles of control and Wnt1-Cre;Plagl1 pat fl/+ mice at PN 28.5. The boxes ( d1, e1 ) show the magnified regions on the right. White arrows show the positive signals. n = 3 per group. Scale bars, 50 μm. f Western blot analysis of the expression of IGF2 in the subchondral bone after knockdown of Plagl1 . Band intensities of IGF2 normalized to β-actin. n = 3 per group. Unpaired two-tailed t-test was used for statistical analysis. GSEA plots of GO term 0006119 ( g ) and 0061621 ( h ) between AdV-EGFP and AdV-CRE-EGFP transfected condyle mesenchymal cells after 4 days of osteogenic induction. n = 3 per group. Analysis of glucose uptake ( i ), intracellular ATP levels ( j ), oxygen consumption rate ( k ), reactive oxygen species ( l ), and L-lactate production ( m ) in AdV-EGFP and AdV-CRE-EGFP transfected condyle mesenchymal cells after 4 days of osteogenic induction. n = 4 per group for i. n = 3 per group for j, k, m. n = 9 per group for l. Unpaired two-tailed t-test was used for statistical analysis. The results are presented as the mean ± standard deviation (SD). * P < 0.05. ns, no significant difference

Journal: International Journal of Oral Science

Article Title: PLAGL1-IGF2 axis regulates osteogenesis of postnatal condyle development

doi: 10.1038/s41368-025-00386-4

Figure Lengend Snippet: Plagl1 deficiency leads to downregulated IGF2 and increased glucose metabolism. a Protein-protein interaction analysis for the relationship between PLAGL1 and genes activated by osteogenic induction while inhibited by knockdown of Plagl1 . b Western blot analysis of the expression of IGF2 during osteogenic induction. c Western blot analysis of the expression of IGF2 after knockdown of Plagl1 . d , e Immunofluorescence staining of IGF2 (green) and DAPI (cyan) in condyles of control and Wnt1-Cre;Plagl1 pat fl/+ mice at PN 28.5. The boxes ( d1, e1 ) show the magnified regions on the right. White arrows show the positive signals. n = 3 per group. Scale bars, 50 μm. f Western blot analysis of the expression of IGF2 in the subchondral bone after knockdown of Plagl1 . Band intensities of IGF2 normalized to β-actin. n = 3 per group. Unpaired two-tailed t-test was used for statistical analysis. GSEA plots of GO term 0006119 ( g ) and 0061621 ( h ) between AdV-EGFP and AdV-CRE-EGFP transfected condyle mesenchymal cells after 4 days of osteogenic induction. n = 3 per group. Analysis of glucose uptake ( i ), intracellular ATP levels ( j ), oxygen consumption rate ( k ), reactive oxygen species ( l ), and L-lactate production ( m ) in AdV-EGFP and AdV-CRE-EGFP transfected condyle mesenchymal cells after 4 days of osteogenic induction. n = 4 per group for i. n = 3 per group for j, k, m. n = 9 per group for l. Unpaired two-tailed t-test was used for statistical analysis. The results are presented as the mean ± standard deviation (SD). * P < 0.05. ns, no significant difference

Article Snippet: To confirm that IGF2 is a downstream target of PLAGL1 during osteoblastic differentiation, we added recombinant human IGF2 (Novoprotein, CF61) at 250 ng/mL in Plagl1 -deficient cells during osteogenic induction.

Techniques: Knockdown, Western Blot, Expressing, Immunofluorescence, Staining, Control, Two Tailed Test, Transfection, Standard Deviation

IGF2 administration partially rescues the osteoblastic differentiation of Plagl1 -deficient cells. qPCR for the expression of osteoblast-linked gene Col1α1 ( a ) and Dmp1 ( b ) with the addition of IGF2 in AdV-EGFP and AdV-CRE-EGFP transfected condyle mesenchymal cells. n = 3 per group. One-way analysis of variance with Tukey’s post-hoc test was used for statistical analysis. c Western blot analysis of the expression of osteoblast-linked protein RUNX2, COl1α1, and DMP1 with the addition of IGF2 in AdV-EGFP and AdV-CRE-EGFP transfected condyle mesenchymal cells. d Immunofluorescence staining of rescued RUNX2 (red) and DAPI (cyan) in AdV-EGFP and AdV-CRE-EGFP transfected condyle mesenchymal cells with the addition of IGF2 or control vector. White arrows showed the positive signals. n = 3 per group. Scale bars, 250 μm. e ALP staining showing osteoblastic capacity in AdV-EGFP and AdV-CRE-EGFP transfected condyle mesenchymal cells with the addition of IGF2 or control vector. n = 3 per group. Scale bars, 200 μm. The results are presented as the mean ± standard deviation (SD). * P < 0.05. ns, no significant difference

Journal: International Journal of Oral Science

Article Title: PLAGL1-IGF2 axis regulates osteogenesis of postnatal condyle development

doi: 10.1038/s41368-025-00386-4

Figure Lengend Snippet: IGF2 administration partially rescues the osteoblastic differentiation of Plagl1 -deficient cells. qPCR for the expression of osteoblast-linked gene Col1α1 ( a ) and Dmp1 ( b ) with the addition of IGF2 in AdV-EGFP and AdV-CRE-EGFP transfected condyle mesenchymal cells. n = 3 per group. One-way analysis of variance with Tukey’s post-hoc test was used for statistical analysis. c Western blot analysis of the expression of osteoblast-linked protein RUNX2, COl1α1, and DMP1 with the addition of IGF2 in AdV-EGFP and AdV-CRE-EGFP transfected condyle mesenchymal cells. d Immunofluorescence staining of rescued RUNX2 (red) and DAPI (cyan) in AdV-EGFP and AdV-CRE-EGFP transfected condyle mesenchymal cells with the addition of IGF2 or control vector. White arrows showed the positive signals. n = 3 per group. Scale bars, 250 μm. e ALP staining showing osteoblastic capacity in AdV-EGFP and AdV-CRE-EGFP transfected condyle mesenchymal cells with the addition of IGF2 or control vector. n = 3 per group. Scale bars, 200 μm. The results are presented as the mean ± standard deviation (SD). * P < 0.05. ns, no significant difference

Article Snippet: To confirm that IGF2 is a downstream target of PLAGL1 during osteoblastic differentiation, we added recombinant human IGF2 (Novoprotein, CF61) at 250 ng/mL in Plagl1 -deficient cells during osteogenic induction.

Techniques: Expressing, Transfection, Western Blot, Immunofluorescence, Staining, Control, Plasmid Preparation, Standard Deviation

Schematic diagram of the PLAGL1-IGF2 axis in mandibular condylar development. Under physiological conditions, PLAGL1 activates Igf2 expression to sustain the IGF2/IGFBP signaling pathway, thereby maintaining glucose metabolic homeostasis and promoting osteoblast differentiation through upregulation of key osteogenic markers of Sp7 , Runx2 , Col1α1 and Dmp1 . In contrast, Plagl1 deficiency suppresses IGF2 signaling, triggering metabolic dysregulation characterized by aberrantly elevated oxidative phosphorylation and glycolysis, which collectively impair osteogenic differentiation and ultimately disrupt mandibular condylar morphogenesis

Journal: International Journal of Oral Science

Article Title: PLAGL1-IGF2 axis regulates osteogenesis of postnatal condyle development

doi: 10.1038/s41368-025-00386-4

Figure Lengend Snippet: Schematic diagram of the PLAGL1-IGF2 axis in mandibular condylar development. Under physiological conditions, PLAGL1 activates Igf2 expression to sustain the IGF2/IGFBP signaling pathway, thereby maintaining glucose metabolic homeostasis and promoting osteoblast differentiation through upregulation of key osteogenic markers of Sp7 , Runx2 , Col1α1 and Dmp1 . In contrast, Plagl1 deficiency suppresses IGF2 signaling, triggering metabolic dysregulation characterized by aberrantly elevated oxidative phosphorylation and glycolysis, which collectively impair osteogenic differentiation and ultimately disrupt mandibular condylar morphogenesis

Article Snippet: To confirm that IGF2 is a downstream target of PLAGL1 during osteoblastic differentiation, we added recombinant human IGF2 (Novoprotein, CF61) at 250 ng/mL in Plagl1 -deficient cells during osteogenic induction.

Techniques: Expressing, Phospho-proteomics